A Phase III, Randomized, doublE-blind, placebo-controlled trial to evaluate Immunogenicity and Safety of the Gam-COVID-Vac combined vector vaccine in prophylactic Treatment for SARS-СoV-2 infection in Saudi Arabia
2022-06-28
عنوان الدراسة
A Phase III, Randomized, doublE-blind, placebo-controlled trial to evaluate Immunogenicity and Safety of the Gam-COVID-Vac combined vector vaccine in prophylactic Treatment for SARS-СoV-2 infection in Saudi Arabia
داعم الدراسة
King Abdullah International Medical Research Center (KAIMRC)
دواء الدراسة
Gam-COVID-Vac combined vector vaccine against the SARS-CoV-2-induced coronavirus infection.
رقم بروتوكول الدراسة
RC20/497/R
حالة الدراسة
Completed
موقع الدراسة
King Abdulaziz Medical City NG (Riyadh)
مرحلة الدراسة
3
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.